By the Editorial Team — referencing Dr. Jay K. Varma’s article on Psychology Today
Read more of Dr. Varma’s work at DrJayVarma.com

In his Fevered Mind column for Psychology Today, infectious disease expert Dr. Jay K. Varma warns that Alaska’s severe gonorrhea outbreak is more than just a local crisis — it’s a national warning about what happens when public health systems are weakened.

Since 2022, Alaska has seen a tenfold increase in cases of disseminated gonorrhea, a dangerous and invasive form of infection that spreads beyond the genitals to affect the bloodstream, joints, and even heart valves. Nearly 90% of recent patients required hospitalization, and many faced additional health challenges such as HIV, hepatitis C, or substance use disorders.

The Alarming Rise of Disseminated Gonorrhea

Gonorrhea is caused by the bacteria Neisseria gonorrhoeae, a sexually transmitted infection that typically affects the genitals, rectum, or throat. What’s different about Alaska’s current outbreak, Dr. Varma explains, is how severe and systemic the infections have become.

Patients are arriving at emergency departments with fever, joint pain, and bloodstream infections instead of the usual burning or discharge symptoms. These are signs of disseminated gonococcal infection — a rare but serious condition that can be life-threatening if untreated.

Health officials suspect a mutated strain of the bacteria combined with reduced access to screening and care may be driving this outbreak among medically vulnerable populations.

The Federal Cuts That Left Alaska Exposed

Dr. Varma connects Alaska’s crisis to a larger, troubling trend: the downsizing of the CDC. On April 1, 2025, two of the agency’s most critical divisions for sexually transmitted infection control were eliminated — the STD Laboratory Reference and Research Branch and the Disease Intervention and Response Branch.

These programs once formed the backbone of America’s STI defense system:

• The STD Lab Branch conducted over 20,000 antibiotic resistance tests each year, tracked new strains, and helped states identify outbreaks early.
• The Intervention and Response Branch deployed CDC staff to state health departments for contact tracing, partner notification, and outbreak management.

Without them, states like Alaska are left to face complex, fast-moving infections with limited support. Local health agencies often lack the specialized labs or field epidemiologists needed to detect resistant strains or stop outbreaks before they spread.

Why This Matters Beyond Alaska

Dr. Varma emphasizes that STI outbreaks rarely remain local. They move through networks of people and partners, often following patterns shaped by housing insecurity, stigma, poverty, and reduced access to care.

When national surveillance weakens, rising infections in one region can easily spread elsewhere before being detected. That means the cuts to CDC programs don’t just endanger Alaska — they weaken the country’s overall ability to respond to infectious disease threats.

A Call to Restore and Reinforce Public Health Capacity

Dr. Varma urges the restoration of these vital CDC programs. Without centralized labs and trained field teams, states lose the capacity to monitor antibiotic resistance — one of the most dangerous challenges in infectious disease control.

He also reminds readers of practical steps individuals can take:

• Get tested regularly if you’re sexually active.
• Encourage your partners to test as well.
• Seek care early if you experience unexplained joint pain, fevers, or other symptoms after sexual contact.

Public health isn’t abstract — it’s the safety net that keeps individual infections from becoming community crises.

Learn More

You can read Dr. Varma’s full article, “STI Outbreak in Alaska: The CDC Has Been Downsized in the Midst of a Gonorrhea Outbreak,” on Psychology Today.

Explore more of his public-health writing and insights at DrJayVarma.com.

FAQs

• What makes disseminated gonorrhea different from standard infections?
• How do antibiotic-resistant STIs develop and spread?
• Why were key CDC STI programs eliminated?
• What can individuals do to protect themselves and their communities?
• How does public-health funding impact STI prevention nationwide?